AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Eligible patients had COPD, were ages 40 or older ... study inhaler or an inhaled corticosteroid-LAMA-LABA combination via separate inhalers. The cohort included 87,751 individuals, from which ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

It features a unique combination of ... symptoms of asthma and COPD, promotes deeper breathing, targets mucus buildup, and provides a natural alternative to inhalers and steroids.

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

“They can be set off by a number of triggers, including viruses, cold weather, exercise, stress, and even hormones, or a combination ... COPD can do is to stop smoking, but there are also ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...